This article covers blockchain news, business news, and technology news.

Quantum BioPharma (QNTM) announced on December 20 that it has purchased $1 million worth of Bitcoin and other cryptocurrencies. The move points to a growing trend of companies incorporating cryptocurrencies into their treasury strategies. However, the company’s shares, which trade on Nasdaq, fell nearly 10% following the announcement.

QNTM is not the only company embracing cryptocurrencies; other companies like Jiva Technologies and Rumble are also making similar moves. Such strategies have the potential to provide a hedge against inflation.

Do you think this trend will continue? Share your thoughts in the comments.